
InFocus Capital Partners
North America, New York, United States, Jericho
Description
InFocus Capital Partners provides seed and early round funding to life science companies, specifically within ophthalmology.
Investor Profile
InFocus Capital Partners has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 20% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Therapeutics, Biotechnology.
Stage Focus
- Series A (60%)
- Series B (20%)
- Convertible Note (10%)
- Seed (10%)
Country Focus
- United States (80%)
- United Kingdom (20%)
Industry Focus
- Health Care
- Therapeutics
- Biotechnology
- Medical
- Pharmaceutical
- Market Research
- Medical Device
- Augmented Reality
- Computer
- Consumer Electronics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.